EU could approve GE/Instrumentarium deal by April:
This article was originally published in Clinica
The European Commission has until April 3 to decide whether to allow General Electric Medical Systems' proposed E2bn ($2.2bn) acquisition of Finnish medical technology firm Instrumentarium to go ahead unimpeded. It could alternatively decide to launch a four-month investigation such as the one being conducted into Siemens' deal with Draegerwerk. GE notified the Commission of its merger plan on February 28.